At a glance
ClinicalIndex Comparison RecordN/ACompleted· 108 enrolled
Drug / intervention
Omega-3 Fatty Acid +3 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Feasibility of Omega-3 Supplementation for Cancer-Related Fatigue
In Brief
A clinical study evaluating Omega-3 Fatty Acid, Placebo, and 2 other interventions for Breast Carcinoma and 2 related conditions. Completed, enrolled 108 participants across 6 sites.
Detailed Summary
This randomized pilot clinical trial studies omega-3 fatty acid in reducing cancer-related fatigue in breast cancer survivors. Supplementation with omega-3 fatty acid may help reduce cancer-related fatigue in breast cancer survivors.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Carcinoma, Cancer, Fatigue
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartFeb 2015
First PostedFeb 2015
Primary CompletionFeb 2016
Study CompletionApr 2016
TodayJul 2026
First PostedFeb 2, 2015
Enrollment StartFeb 1, 2015
Primary CompletionFeb 1, 2016
Study CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 11.4 years ago
Interventions
Omega-3 Fatty Aciddietary
Given PO
Placeboother
Given PO
Questionnaire Administrationother
Ancillary studies
Laboratory Biomarker Analysisother
Correlative studies